These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 27098592)
21. Treatment of inflammatory muscle disease in adults. Tournadre A; Dubost JJ; Soubrier M Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies. Schiavo AL; Puca RV; Ruocco V; Ruocco E Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689 [TBL] [Abstract][Full Text] [Related]
23. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory myopathies: how to treat the difficult cases. Mastaglia FL; Zilko PJ J Clin Neurosci; 2003 Jan; 10(1):99-101. PubMed ID: 12464534 [TBL] [Abstract][Full Text] [Related]
26. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011). Wang A; Smith JR; Creevy KE J Small Anim Pract; 2013 Aug; 54(8):399-404. PubMed ID: 23879827 [TBL] [Abstract][Full Text] [Related]
27. Evolving new therapies of autoimmune hepatitis. Vierling JM; Flores PA Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583 [TBL] [Abstract][Full Text] [Related]
28. Classification, diagnosis, and management of idiopathic inflammatory myopathies. Lazarou IN; Guerne PA J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of steroid-resistant polymyositis and dermatomyositis]. Mimura T; Kanda H; Kubo K Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154 [TBL] [Abstract][Full Text] [Related]
31. Cutaneous lupus erythematosus: update of therapeutic options part II. Kuhn A; Ruland V; Bonsmann G J Am Acad Dermatol; 2011 Dec; 65(6):e195-213. PubMed ID: 20800319 [TBL] [Abstract][Full Text] [Related]
32. Immunotherapies in neurologic disorders. Graves D; Vernino S Med Clin North Am; 2012 May; 96(3):497-523, x. PubMed ID: 22703853 [TBL] [Abstract][Full Text] [Related]
33. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin. Shahani L BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859 [TBL] [Abstract][Full Text] [Related]
34. Treatment of polymyositis and dermatomyositis. Kaye SA; Isenberg DA Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361 [TBL] [Abstract][Full Text] [Related]
35. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics. Moghadam-Kia S; Oddis CV; Aggarwal R Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526 [TBL] [Abstract][Full Text] [Related]
36. Treatment of the inflammatory myopathies: update and practical recommendations. Hengstman GJ; van den Hoogen FH; van Engelen BG Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792 [TBL] [Abstract][Full Text] [Related]
37. Therapy of polymyositis and dermatomyositis. Marie I; Mouthon L Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984 [TBL] [Abstract][Full Text] [Related]